Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 171

Khatabook looks to $70m

Accounting and invoicing app developer Khatabook is reportedly closing in on a funding round featuring existing investor Tencent that will value it at up to $300m.

Feb 26, 2020

HeadSpin turns to Dell to raise $60m

The Wipro, Alphabet and Telstra-backed software optimisation platform has raised funding in a series C round co-led by Dell Technologies Capital at a $1.16bn valuation.

Feb 26, 2020

Rupeek scoops up $60m

Gold-based lender Rupeek, which counts Bertelsmann India Investments as a backer, has snagged funding at a valuation of more than $300m.

Feb 25, 2020

Tarana starts downloading $60m

Tarana, a broadband services provider advancing research from UC Berkeley, has raised $24m in funding with commitments for an additional $36m.

Feb 24, 2020

Guoquan Shihui cooks up $50m series B

The hot pot and barbeque ingredient retailer, which counts Sanquan Food as an investor, has now secured more than $53m in the past six months.

Feb 24, 2020

Volocopter tops up series C to $94m

DB Schenker, Mitsui Sumitomo Insurance and MS&AD Ventures have helped the airborne taxi developer extend its series C round, which already included Geely Holding Group.

Feb 21, 2020

ZeroFox locks in $74m

Intel Capital has joined various returning investors in a $74m round that will help ZeroFox bolster the artificial intelligence capabilities of its brand protection software.

Feb 21, 2020

IntelyCare works out $45m in funding

Healthcare staff management platform IntelyCare attracted Kaiser Permanente Ventures as a new investor in a series B round that increased its overall funding to $59m.

Feb 21, 2020

BellFace meets corporates for fresh funding

Globis, Nihon Unisys and Yahoo Japan have chipped into a $47.3m round for the online sales support platform developer, with half the capital to go to increasing headcount.

Feb 21, 2020

Spruce ups funding with $88m

Proceeds from the Novo-backed series B round will be used to advance Spruce Biosciences' congenital adrenal hyperplasia candidate into phase 2 trials.

Feb 20, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here